Company
Resources
Webinars
- Staying ahead of the virus: From a multispecies discovery strategy to highly efficacious, clinically suitable multi-antibody cocktails targeting SARS-CoV-2
- High throughput identification of synergistic antibody cocktails and broad epitope coverage to combat SARS-CoV-2
- The Polytope™ Advantage to fight COVID-19: unlocking synergistic effects via broad epitope coverage
- High throughput identification of genetically distinct, target-specific antibodies
- DeepDisplay™: a ground‐breaking and influential human lead antibody discovery platform utilizing OmniAb® animals
- Picking up the Pace: Maximizing molecular quality of multipass membrane protein-targeting antibodies
- Transcript: Optimizing antibody discovery strategy for clinical success of next-gen immuno-oncology therapeutics
Posters
- Humanization of functional antibodies against membrane spanning proteins488 KB PDF
- DeepDisplay™: a ground‐breaking and influential human lead antibody discovery platform utilizing OmniAb® animals270 KB PDF
- Isolation of target-specific antibodies by deep mining the antibody repertoire of immunized OmniChicken® by DeepDisplay™1 MB PDF
- Successful rabbit mAb CDR grafting: The first step towards clinically suitable monoclonal antibodies933 KB PDF
Flyers
- ImmunoPrecise Company Brochure2 MB PDF
- We Deliver Your Bispecific Antibodies607 KB PDF
- We Succeed with Transgenic Animal Technologies317 KB PDF
- B cell Select™: Phosphopeptide Case Study365 KB PDF
- DeepDisplay™ Antibody Discovery Platform298 KB PDF
- B cell Select™: Rabbit B cell Case Study289 KB PDF
- We Deliver Elusive Antibodies1 MB PDF
- rPEx™ Transient Production of Recombinant Proteins740 KB PDF
- Antibodies For CAR-T170 KB PDF
Terms & Conditions
- General Condition of Sale166 KB PDF